JOP20240177A1 - طرق إنقاص الوزن والحفاظ على كتلة العضلات الهيكلية - Google Patents

طرق إنقاص الوزن والحفاظ على كتلة العضلات الهيكلية

Info

Publication number
JOP20240177A1
JOP20240177A1 JOJO/P/2024/0177A JOP20240177A JOP20240177A1 JO P20240177 A1 JOP20240177 A1 JO P20240177A1 JO P20240177 A JOP20240177 A JO P20240177A JO P20240177 A1 JOP20240177 A1 JO P20240177A1
Authority
JO
Jordan
Prior art keywords
skeletal muscle
muscle mass
methods
losing weight
maintaining skeletal
Prior art date
Application number
JOJO/P/2024/0177A
Other languages
Arabic (ar)
English (en)
Inventor
Jorkasky Diane
Khan Shaharyar
PORTELL Francisco
Original Assignee
Rivus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivus Pharmaceuticals Inc filed Critical Rivus Pharmaceuticals Inc
Publication of JOP20240177A1 publication Critical patent/JOP20240177A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JOJO/P/2024/0177A 2022-02-07 2024-08-04 طرق إنقاص الوزن والحفاظ على كتلة العضلات الهيكلية JOP20240177A1 (ar)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US202263382456P 2022-11-04 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (1)

Publication Number Publication Date
JOP20240177A1 true JOP20240177A1 (ar) 2024-08-04

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2024/0177A JOP20240177A1 (ar) 2022-02-07 2024-08-04 طرق إنقاص الوزن والحفاظ على كتلة العضلات الهيكلية

Country Status (12)

Country Link
US (1) US20250134864A1 (cg-RX-API-DMAC7.html)
EP (1) EP4475841A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505187A (cg-RX-API-DMAC7.html)
KR (1) KR20240146052A (cg-RX-API-DMAC7.html)
AU (1) AU2023216366A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243640A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002341A1 (cg-RX-API-DMAC7.html)
GE (1) GEAP202416578A (cg-RX-API-DMAC7.html)
IL (1) IL314684A (cg-RX-API-DMAC7.html)
JO (1) JOP20240177A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024009646A (cg-RX-API-DMAC7.html)
WO (1) WO2023150767A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Also Published As

Publication number Publication date
JP2025505187A (ja) 2025-02-21
AU2023216366A1 (en) 2024-08-15
GEAP202416578A (en) 2024-11-11
MX2024009646A (es) 2024-11-08
IL314684A (en) 2024-10-01
CL2024002341A1 (es) 2025-01-17
WO2023150767A1 (en) 2023-08-10
CA3243640A1 (en) 2023-08-10
KR20240146052A (ko) 2024-10-07
EP4475841A1 (en) 2024-12-18
US20250134864A1 (en) 2025-05-01

Similar Documents

Publication Publication Date Title
AR119228A1 (es) Una cepa de bacilo y métodos para su utilización en la promoción del crecimiento de las plantas
AR117184A1 (es) Composiciones herbicidas para tierras de pastoreo y métodos para aplicar las mismas
MX2022006533A (es) Un esteroide c21-n-pirazolilo 19-nor c3,3-disustituido y metodos de uso del mismo.
SA523451582B1 (ar) Ccr8 الأجسام المضادة لـ
WO2021113401A3 (en) Histone deacytlase 6 modulation of titin protein mediated cardiac tissue stiffness and method for same
EP4069262A4 (en) METHODS FOR DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND PARTS OF ORGANS
GEAP202416578A (en) Methods of weight loss and preserving skeletal muscle mass
MX2023006512A (es) Método para preparar pralsetinib.
MX2021011524A (es) Inhibidores de proteina arginina n-metiltransferasa 5 (prmt5) y usos de los mismos.
ZA202302035B (en) Method for improving land utilization rate of macadamia spp. forest
AR120099A1 (es) Cepa de levadura que produce glutatión y procedimiento para producir glutatión usando la misma
MX2022001703A (es) Metodos para producir estiercol tratado.
EP4013398C0 (en) IMPROVED PROCESS FOR THE PREPARATION OF VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
MX2025003568A (es) Compuestos y composiciones útiles como inhibidores de las proteínas inhibidoras de la apoptosis (iap)
NZ622309A (en) Method of soil compaction and densification
MX2021009862A (es) Metodos para obtener celulas de musculo liso inducidas.
MX2025014322A (es) Metodos, composiciones y dispositivos para el aislamiento y analisis de expresion de regiones de interes de un tejido
MX2025004326A (es) Metodo para preparar maribavir
CO2022009062A2 (es) Composición para la preparación de alulosa y procedimiento para la preparación de alulosa mediante el uso de la misma
EA202190045A1 (ru) Составы/композиции, содержащие ибрутиниб
MX2023004881A (es) Inhibidores de pde9 para el tratamiento de insuficiencia cardíaca.
EP4119655A4 (en) YARROWIA SP VARIANT. AND METHOD FOR PREPARING FAT USING THE SAME
EP4028625B8 (en) Method of planning and/or performing an offshore well operation
MX2024008143A (es) Injertos de tejido amniotico y metodos para preparar y usar los mismos.
EA202092108A1 (ru) Способ получения стимуляторов растворимой гуанилатциклазы